Your browser doesn't support javascript.
loading
Performance of the Surprise Question Compared to Prediction Models in Hemodialysis Patients: A Prospective Study.
Malhotra, Rakesh; Tao, Xia; Wang, Yuedong; Chen, Yuqi; Apruzzese, Rebecca H; Balter, Paul; Xiao, Qingqing; Usvyat, Len A; Kotanko, Peter; Thijssen, Stephan.
Afiliação
  • Malhotra R; Division of Nephrology and Hypertension, University of California San Diego, San Diego, California, USA.
  • Tao X; Renal Research Institute, New York, New York, USA.
  • Wang Y; Department of Statistics and Applied Probability, University of California - Santa Barbara, Santa Barbara, California, USA.
  • Chen Y; Department of Statistics and Applied Probability, University of California - Santa Barbara, Santa Barbara, California, USA.
  • Apruzzese RH; Renal Research Institute, New York, New York, USA.
  • Balter P; Renal Research Institute, New York, New York, USA.
  • Xiao Q; Renal Research Institute, New York, New York, USA.
  • Usvyat LA; Fresenius Medical Care North America, Waltham, Massachusetts, USA.
  • Kotanko P; Renal Research Institute, New York, New York, USA.
  • Thijssen S; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Am J Nephrol ; 46(5): 390-396, 2017.
Article em En | MEDLINE | ID: mdl-29130949
ABSTRACT

BACKGROUND:

The surprise question (SQ) ("Would you be surprised if this patient were still alive in 6 or 12 months?") is used as a mortality prognostication tool in hemodialysis (HD) patients. We compared the performance of the SQ with that of prediction models (PMs) for 6- and 12-month mortality prediction.

METHODS:

Demographic, clinical, laboratory, and dialysis treatment indicators were used to model 6- and 12-month mortality probability in a HD patients training cohort (n = 6,633) using generalized linear models (GLMs). A total of 10 nephrologists from 5 HD clinics responded to the SQ in 215 patients followed prospectively for 12 months. The performance of PM was evaluated in the validation (n = 6,634) and SQ cohorts (n = 215) using the areas under receiver operating characteristics curves. We compared sensitivities and specificities of PM and SQ.

RESULTS:

The PM and SQ cohorts comprised 13,267 (mean age 61 years, 55% men, 54% whites) and 215 (mean age 62 years, 59% men, 50% whites) patients, respectively. During the 12-month follow-up, 1,313 patients died in the prediction model cohort and 22 in the SQ cohort. For 6-month mortality prediction, the GLM had areas under the curve of 0.77 in the validation cohort and 0.77 in the SQ cohort. As for 12-month mortality, areas under the curve were 0.77 and 0.80 in the validation and SQ cohorts, respectively. The 6- and 12-month PMs had sensitivities of 0.62 (95% CI 0.35-0.88) and 0.75 (95% CI 0.56-0.94), respectively. The 6- and 12-month SQ sensitivities were 0.23 (95% CI 0.002-0.46) and 0.35 (95% CI 0.14-0.56), respectively.

CONCLUSION:

PMs exhibit superior sensitivity compared to the SQ for mortality prognostication in HD patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Modelos Estatísticos / Diálise Renal / Medição de Risco / Falência Renal Crônica Tipo de estudo: Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Modelos Estatísticos / Diálise Renal / Medição de Risco / Falência Renal Crônica Tipo de estudo: Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article